ArticleNeurosciences (Riyadh, Saudi Arabia)2019
Multiple Sclerosis Patients Knowledge in Saudi Arabia.
Article in Neurosciences (Riyadh, Saudi Arabia), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review to explore patients' MS knowledge and MS risk knowledge.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024Pooled it
- Analysis of the comprehension and familiarity among the Saudi Arabian population regarding multiple sclerosis.Journal of family medicine and primary care · 2026Article
- Article
- Motherhood and pregnancy concerns of Saudi females with multiple sclerosis in Riyadh city: A quantitative analysis.Neurosciences (Riyadh, Saudi Arabia) · 2025Article
- Evaluating public awareness and knowledge of multiple sclerosis in Tobruk, Libya: a comprehensive cross-sectional study.BMC public health · 2024Article
- Community Awareness Toward Multiple Sclerosis in the Western Region of Saudi Arabia: A Cross-Sectional Study.Cureus · 2022Article
- Article
- Assessment of Multiple Sclerosis Awareness and Knowledge among the Community of Jeddah, Saudi Arabia.Journal of neurosciences in rural practice · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess Multiple Sclerosis (MS) patients` knowledge in Saudi Arabia (SA) and in which aspect of the disease do patient need more awareness.
methodsA cross-sectional web-based survey has been conducted between June and August 2017. It consisted of 2 parts: sociodemographic and 23 multiple choice questions chosen from the previously validated MS Knowledge Questionnaire (MSKQ). The survey has been sent to 500 MS patients.
resultsA total of 218 MS patients filled the questionnaire where only 200 included in the study. Female MS patient represents 66% of all the participants. More than half of the patients had achieved their bachelor degree. The total mean of the correct answer for both male and female found to be 58.98% (+/-SD 15.06%). Most patients were aware that MS is a disease of central nervous system (93%), autoimmune disease (79%), not contagious (90%), or inherited (64.5%). However, few patients were aware that there is no single test to diagnose MS (28.5%), and intravenous injection of contrast during MRI reveals new lesions (18.5%). Only (37%) knew what is `Relapsing-remitting` MS. The MS knowledge is positively correlated with the educational level.
conclusionPatients with MS in SA have less knowledge in the disease`s types, workups, and treatment efficacy. While in contrast, they have more awareness of the disease`s pathophysiology. Patient`s awareness programs should aid more knowledge among MS patients in SA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.